EUVIMEDDescoperă EUVIMED
Open access · CC BY-NC-ND 4.0

Ginsenoside Rh1 Attenuates Alzheimer's Disease‐Like Deficits by Modulating Oxidative Stress and Mitochondrial Dysfunction via SIRT1 ‐Related Signaling

Shi-Lu Li, Tao Lin, Wan-Chen Zou, Ya-Jun Wang iD, Jing-Tian Zhang, Zi Wang, Hong-Yuan Li, Long Chen, Li-Chun Zhao, Shen Ren, Wei Li iD

Phytotherapy Research · 2026-11 · 40 (11) · 6767-6790

DOI: 10.1002/ptr.70459 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2026-09-24. Written by Shi-Lu Li and 10 co-authors. Institution: College of Chinese Medicinal Materials, Jilin Provincial International Joint Research Center for the Development and Utilization of Authentic Medicin…. Major MEDLINE topics: Ginsenosides, Alzheimer Disease, Oxidative Stress, Sirtuin 1. 61 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Natural Science Foundation of China, the Science and Technology Research Project of the Education Department of Jilin Province, The China Postdoctoral Science Foundation.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Alzheimer's disease (AD) remains a progressive neurodegenerative disorder with limited therapeutic options. Ginsenoside Rh1 has been reported to possess neuroprotective properties, yet its specific role and underlying mechanisms in AD are not fully understood. This study aimed to investigate the protective effects of Rh1 against AD‐related deficits and elucidate its molecular mechanisms. Using a D‐galactose and AlCl 3 ‐induced AD‐like mouse model and an okadaic acid (OA)‐injured HT22 hippocampal neuronal cell model, we demonstrated that Rh1 administration significantly ameliorated spatial learning and memory impairments, reduced hippocampal neuronal damage, and suppressed abnormal Tau hyperphosphorylation. Serum metabolomics analysis revealed that Rh1 markedly modulated amino acid metabolism pathways in AD‐like mice, notably increasing aspartate (Asp) levels and decreasing glutamate (Glu) levels. Mechanistically, Rh1 activated the Nrf2 antioxidant pathway, thereby alleviating cellular oxidative stress. Concurrently, Rh1 ameliorated mitochondrial dysfunction by enhancing mitochondrial biogenesis, improving the mitochondrial fusion‐fission balance, and modulating mitophagy. Importantly, the SIRT1 inhibitor EX‐527 and SIRT1 knockdown both significantly reversed these protective effects. Cellular thermal shift assay and molecular docking suggested a potential interaction between Rh1 and SIRT1. In conclusion, our findings indicate that ginsenoside Rh1 exerts neuroprotective effects against AD in vivo and in vitro, at least partly through SIRT1‐related signaling, which subsequently attenuates oxidative stress and ameliorates mitochondrial dysfunction. These results suggest that Rh1 may represent a promising candidate for further investigation for AD intervention.

Subjects

MeSH terms (MEDLINE)

GinsenosidesAlzheimer DiseaseOxidative StressSirtuin 1MitochondriaNeuroprotective AgentsAnimalsMiceSignal TransductionHippocampusMaleDisease Models, AnimalNeuronsMolecular Docking SimulationCell LineAluminum ChlorideGalactoseMice, Inbred C57BL

Author keywords

Alzheimer's diseaseSIRT1ginsenoside Rh1mitochondrial dysfunctionoxidative stressserum metabolomics

Substances

GinsenosidesSirtuin 1Neuroprotective AgentsSirt1 protein, mouseginsenoside Rh1Aluminum ChlorideGalactose

Authors and institutions

  • College of Chinese Medicinal Materials, Jilin Provincial International Joint Research Center for the Development and Utilization of Authentic Medicinal Materials, Jilin Agricultural University, Changchun, China.
  • College of Life Sciences, Jilin Agricultural University, Changchun, China.
  • College of Pharmaceutical Sciences, Guizhou University of Traditional Chinese Medicine, Guiyang, China.

ORCID profiles: Ya-Jun Wang, Wei Li

Funding

  • National Natural Science Foundation of China
  • the Science and Technology Research Project of the Education Department of Jilin Province
  • The China Postdoctoral Science Foundation

Cite

APA

Li, S. L., Lin, T., Zou, W. C., Wang, Y. J., Zhang, J. T., Wang, Z., Li, H. Y., Chen, L., Zhao, L. C., Ren, S., & Li, W. (2026). Ginsenoside Rh1 Attenuates Alzheimer's Disease‐Like Deficits by Modulating Oxidative Stress and Mitochondrial Dysfunction via SIRT1 ‐Related Signaling. Phytotherapy Research, 40(11), 6767-6790. https://doi.org/10.1002/ptr.70459

Vancouver

Li SL, Lin T, Zou WC, Wang YJ, Zhang JT, Wang Z, et al. Ginsenoside Rh1 Attenuates Alzheimer's Disease‐Like Deficits by Modulating Oxidative Stress and Mitochondrial Dysfunction via SIRT1 ‐Related Signaling. Phytotherapy Research. 2026;40(11):6767-6790. doi:10.1002/ptr.70459

BibTeX
@article{Li2026,
  author = {Li, Shi-Lu and Lin, Tao and Zou, Wan-Chen and Wang, Ya-Jun and Zhang, Jing-Tian and Wang, Zi and Li, Hong-Yuan and Chen, Long and Zhao, Li-Chun and Ren, Shen and Li, Wei},
  title = {Ginsenoside Rh1 Attenuates Alzheimer's Disease‐Like Deficits by Modulating Oxidative Stress and Mitochondrial Dysfunction via SIRT1 ‐Related Signaling},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {11},
  pages = {6767--6790},
  doi = {10.1002/ptr.70459}
}
Start for free →